Literature DB >> 20595940

Neuroprotection of sex steroids.

M Liu1, M H Kelley, P S Herson, P D Hurn.   

Abstract

Sex steroids are essential for reproduction and development in animals and humans, and sex steroids also play an important role in neuroprotection following brain injury. New data indicate that sex-specific responses to brain injury occur at the cellular and molecular levels. This review summarizes the current understanding of neuroprotection by sex steroids, particularly estrogen, androgen, and progesterone, based on both in vitro and in vivo studies. Better understanding of the role of sex steroids under physiological and pathological conditions will help us to develop novel effective therapeutic strategies for brain injury.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20595940      PMCID： PMC3036837     

Source DB:  PubMed          Journal:  Minerva Endocrinol        ISSN： 0391-1977            Impact factor:   2.184


  100 in total

1.  Role of cocaine- and amphetamine-regulated transcript in estradiol-mediated neuroprotection.

Authors:  Yun Xu; Wenri Zhang; Judith Klaus; Jennifer Young; Ines Koerner; Laird C Sheldahl; Patricia D Hurn; Francisco Martínez-Murillo; Nabil J Alkayed
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-13       Impact factor: 11.205

Review 2.  Multiple pathways transmit neuroprotective effects of gonadal steroids.

Authors:  Damani N Bryant; Laird C Sheldahl; Lisa K Marriott; Robert A Shapiro; Daniel M Dorsa
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

3.  Androgens activate mitogen-activated protein kinase signaling: role in neuroprotection.

Authors:  Thuy-Vi V Nguyen; Mingzhong Yao; Christian J Pike
Journal:  J Neurochem       Date:  2005-07-11       Impact factor: 5.372

Review 4.  Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies.

Authors:  Judith L Turgeon; Molly C Carr; Pauline M Maki; Michael E Mendelsohn; Phyllis M Wise
Journal:  Endocr Rev       Date:  2006-06-09       Impact factor: 19.871

5.  Estradiol reduces activity of the blood-brain barrier Na-K-Cl cotransporter and decreases edema formation in permanent middle cerebral artery occlusion.

Authors:  Martha E O'Donnell; Tina I Lam; Lien Q Tran; Shahin Foroutan; Steven E Anderson
Journal:  J Cereb Blood Flow Metab       Date:  2006-01-18       Impact factor: 6.200

6.  Aromatase expression in the human temporal cortex.

Authors:  J G Yague; A Muñoz; P de Monasterio-Schrader; J Defelipe; L M Garcia-Segura; I Azcoitia
Journal:  Neuroscience       Date:  2006-01-19       Impact factor: 3.590

7.  Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats.

Authors:  Qingmin Guo; Iqbal Sayeed; Lon M Baronne; Stuart W Hoffman; Rachida Guennoun; Donald G Stein
Journal:  Exp Neurol       Date:  2006-01-27       Impact factor: 5.330

Review 8.  Novel cellular phenotypes and subcellular sites for androgen action in the forebrain.

Authors:  L L DonCarlos; S Sarkey; B Lorenz; I Azcoitia; D Garcia-Ovejero; C Huppenbauer; L-M Garcia-Segura
Journal:  Neuroscience       Date:  2005-11-28       Impact factor: 3.590

9.  Oestrogen and stroke: the potential for harm as well as benefit.

Authors:  I M Macrae; H V Carswell
Journal:  Biochem Soc Trans       Date:  2006-12       Impact factor: 5.407

10.  Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion.

Authors:  Iqbal Sayeed; Qingmin Guo; Stuart W Hoffman; Donald G Stein
Journal:  Ann Emerg Med       Date:  2006-02-21       Impact factor: 5.721
View more
  44 in total

1.  Aging and substitutive hormonal therapy influence in regional and subcellular distribution of ERα in female rat brain.

Authors:  Ana Navarro; Eva Del Valle; Cristina Ordóñez; Eva Martínez; Cristina Pérez; Ana Alonso; Celestino González; Jorge Tolivia
Journal:  Age (Dordr)       Date:  2012-05-10

2.  Early menopause and other gynecologic risk indicators for chronic fatigue syndrome in women.

Authors:  Roumiana S Boneva; Jin-Mann S Lin; Elizabeth R Unger
Journal:  Menopause       Date:  2015-08       Impact factor: 2.953

Review 3.  Pregnancy, postpartum and parity: Resilience and vulnerability in brain health and disease.

Authors:  Nicholas P Deems; Benedetta Leuner
Journal:  Front Neuroendocrinol       Date:  2020-01-24       Impact factor: 8.606

Review 4.  Role of estrogen treatment in the management of schizophrenia.

Authors:  Jayashri Kulkarni; Emmy Gavrilidis; Roisin Worsley; Emily Hayes
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

5.  Sex difference in sensitivity to allopregnanolone neuroprotection in mice correlates with effect on spontaneous inhibitory post synaptic currents.

Authors:  Melissa H Kelley; Masayuki Kuroiwa; Noriko Taguchi; Paco S Herson
Journal:  Neuropharmacology       Date:  2011-05-27       Impact factor: 5.250

6.  Single dose of 17β-estradiol provides transient neuroprotection in female juvenile mice after cardiac-arrest and cardiopulmonary resuscitation.

Authors:  N Quillinan; A L Dingman; G Deng; S Tatum; J E Orfila; A C Clevenger; J Klawitter; R J Traystman; P S Herson
Journal:  Neurochem Int       Date:  2018-11-22       Impact factor: 3.921

Review 7.  Progesterone and autoimmune disease.

Authors:  Grant C Hughes
Journal:  Autoimmun Rev       Date:  2011-12-13       Impact factor: 9.754

Review 8.  Sex differences in stroke.

Authors:  Roy A M Haast; Deborah R Gustafson; Amanda J Kiliaan
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-03       Impact factor: 6.200

9.  Differential effects of synthetic progestagens on neuron survival and estrogen neuroprotection in cultured neurons.

Authors:  Anusha Jayaraman; Christian J Pike
Journal:  Mol Cell Endocrinol       Date:  2014-01-11       Impact factor: 4.102

10.  Persistent Hypogonadotropic Hypogonadism in Men After Severe Traumatic Brain Injury: Temporal Hormone Profiles and Outcome Prediction.

Authors:  David J Barton; Raj G Kumar; Emily H McCullough; Gary Galang; Patricia M Arenth; Sarah L Berga; Amy K Wagner
Journal:  J Head Trauma Rehabil       Date:  2016 Jul-Aug       Impact factor: 2.710
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.